Home > Drug Search >
  • company_query: Ambrilia
  •   > 
Drug Filter
Category:
chemistry (25) biology (2)
Status:
Approved (1) NDA Filing (1) BLA Filing (1) Phase Ⅲ (3) Phase Ⅱ (15) Phase Ⅰ (6)
Clinical Stage:
Pending (7) Active (6) Discontinued (13)
Bio-Type:
Vaccine (1) Whole antibody (1)
Indication:
Acne (1) Alzheimer's disease (AD) (1) Angina pectoris (1) Depression (1) Diabetic macular edema (1) Erectile dysfunction (ED) (2) Cataract (1) Glaucoma (1) Cytomegalovirus infections (1) HCV infection (1) HIV infection (3) Hypertension (2) Leiomyoma (1) Melanoma (1) Metastatic prostate carcinoma (1) Obesity (1) Ocular hypertension (1) Pancreatic cancer (1) Parkinson's disease (PD) (1) Prostate cancer (1) Rheumatoid arthritis (RA) (1) Solid tumours (5) Type 2 diabetes (1) Head and neck cancer (1) Fungal infection (1) Age-related macular degeneration (AMD) (1) Stroke (1) Glioblastoma (1) Brain cancer (1) Lipodystrophy (1) Cartilage and bone regeneration (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top